API
| PRODUCT | THERAPEUTIC CATEGORY | SPECIEICATIONS | EDMF (CTD) |
USDMF | COS |
| Ramipril | Anti-Hypertensive | BP/EP/USP | yes | yes | Received |
| Quinapril HCl | Anti-Hypertensive | USP | yes | yes | |
| Benazepril HCl | Anti-Hypertensive | USP | yes | yes | |
| Perindopril | Anti-Hypertensive | BP/EP | yes | ||
| Ranolazine Di- HCI / Base | Anti-Hypertensive | INHOUSE | |||
| Lacidipine | Anti-Hypertensive | BP/EP | |||
| Budesonide | Anti-Asthamatic | BP/EP/USP | yes | yes | Applied |
| Bambuterol HCl | Anti-Asthamatic | BP/EP | yes | ||
| R-Salbutamol Sulphate | Anti-Asthamatic | INHOUSE | yes | ||
| Levalbuterol HCI | Anti-Asthamatic | INHOUSE | yes | yes | |
| Levalbuterol Tartrate | Anti-Asthamatic | INHOUSE | yes | yes | |
| Salmeterol Xinofoate | Anti-Asthamatic | EP/BP | |||
| Ipratropium Bromide | Anti-Asthamatic | EP / BP | |||
| Acefylline Piperazine | Anti-Asthamatic | BP | yes | ||
| Theofylline | Anti-Asthamatic | BP/EP/USP | yes | ||
| Etofylline | Anti-Asthamatic | BP | yes | ||
| Choline Theofylline | Anti-Asthamatic | BP | |||
| Aminophylline | Anti-Asthamatic | BP | yes | ||
| Gemcitabine HCl | Anti-Cancer | USP | |||
| Bicalutamide | Anti-Cancer | INHOUSE | yes | yes | |
| Ifosfamide | Anti-Cancer | BP/EP/USP | |||
| Mesna | Anti-Cancer | EP/BP | yes | Applied | |
| Mercaptopurine | Anti-Cancer | BP/EP/USP | |||
| Irinotecan | Anti-Cancer | INHOUSE | |||
| Venlafaxine HCl | CNS Agent | EP | yes | yes | Applied |
| Quetiapine | CNS Agent | INHOUSE | yes | yes | |
| Carbamazepine | CNS Agent | BP/EP/USP | |||
| Oxcarbazepine | CNS Agent | INHOUSE | |||
| Caffeine | CNS Agent | BP/EP/USP | yes | ||
| Bupropion | CNS Agent | USP | |||
| Fluticasone Propionate | Anti-Allergic | BP/EP/USP | yes | yes | Applied |
| Mometasone Furoate | Anti-Allergic | BP/EP/USP | yes | yes | Applied |
| Desonide | Anti-Allergic | INHOUSE | |||
| Triamcinolone acetonide | Anti-Allergic | BP/EP/USP | |||
| Adapalene | Anti-Acne | INHOUSE | |||
| Deferiprone | Anti-Thalassaemic | INHOUSE | |||
| Note : | |||||
|
